Genpharmasec Ltd (531592) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531592 | NSE: | Dyes & Pigments | Small Cap

Genpharmasec Share Price

1.38 -0.05 -3.50%
as on 05-Dec'25 16:59

Genpharmasec Ltd (531592) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531592 | NSE: | Dyes & Pigments | Small Cap

DeciZen - make an informed investing decision on Genpharmasec

Based on:

M-Cap below 100cr DeciZen not available

Genpharmasec stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
23.34
Market Cap:
76.4 Cr.
52-wk low:
1.4
52-wk high:
4.3

Is Genpharmasec Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Genpharmasec: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Genpharmasec Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 189%13.6%48.6%2.7%5.9%7.6%-2.5%2%2%5.4%-
Value Creation
Index
12.50.02.5-0.8-0.6-0.5-1.2-0.9-0.9-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00.50.10.416.521.327.325.530.43366
Sales YoY Gr.-NA-83.3%375%4,242.1%29.2%28.2%-6.6%19.2%8.4%-
Adj EPS 000.1000-00-000.1
YoY Gr.-NA200%-88.9%200%0%-100%NA-100%NA-
BVPS (₹) -0.1-1.7-1.60.60.50.40.30.31.21.21.2
Adj Net
Profit
000.10.211.3-0.21.1-0.12.43
Cash Flow from Ops. 0.1-0.10.1-6.41.4-2.1-2.3-3.1-2.33.5-
Debt/CF from Ops. 9.7-21.36.80000-1-1.40.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA14.8%6.5%8.4%
Adj EPS NA5.9%NANA
BVPSNA19.6%53.8%2.6%
Share Price 21.9% -29.3% -17.6% -61.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-1.8-1.7-5.42.156.3-1.27.1-0.23.74.9
Op. Profit
Mgn %
0-12.4-31.4-23.245.6-1.910.51.32.2
Net Profit
Mgn %
03.258.557.46.15.9-0.84.3-0.37.35.1
Debt to
Equity
-1.1-1.2-1.100000.20.10.10
Working Cap
Days
01991,1524,33127928122723928747385
Cash Conv.
Cycle
011-1,804174212312817017515740

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Genpharmasec Ltd.

Standalone Consolidated
TTM EPS (₹) 0.1 0
TTM Sales (₹ Cr.) 65.6 67.2
BVPS (₹.) 1.2 1.2
Reserves (₹ Cr.) 14 10
P/BV 1.11 1.16
PE 23.34 139.44
From the Market
52 Week Low / High (₹) 1.36 / 4.32
All Time Low / High (₹) 0.13 / 10.81
Market Cap (₹ Cr.) 76.4
Equity (₹ Cr.) 55.4
Face Value (₹) 1
Industry PE 34.8

Management X-Ray of Genpharmasec:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Genpharmasec - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Genpharmasec

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales00.480.080.3816.5021.3127.3225.5230.4132.96
Operating Expenses 0.110.540.110.4615.8520.1127.8425.2630.2532.52
Manufacturing Costs00000.040.150.240.162.911.70
Material Costs00.420015.2419.2026.5723.4024.2329.14
Employee Cost 0.010.010.020.020.130.190.250.540.760.67
Other Costs 0.090.110.090.450.450.570.781.162.341.01
Operating Profit -0.11-0.06-0.03-0.090.651.19-0.520.260.160.44
Operating Profit Margin (%) --12.4%-31.4%-23.2%3.9%5.6%-1.9%1.0%0.5%1.3%
Other Income 0.090.070.090.370.560.330.090.100.723.43
Interest 00000000.060.390.29
Depreciation 000000.010.010.020.020.13
Exceptional Items 0.12000000000
Profit Before Tax 0.100.010.060.291.211.51-0.440.280.473.45
Tax -0-00.020.060.200.25-0.23-0.840.420.98
Profit After Tax 0.100.020.050.231.011.26-0.211.120.052.47
PAT Margin (%) -3.2%58.5%61.6%6.1%5.9%-0.8%4.4%0.2%7.5%
Adjusted EPS (₹)0.00.00.10.00.00.00.00.00.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund -0.92-0.91-0.8620.1117.5314.6615.3715.3364.5766.55
Share Capital 6.520.330.3321.6921.6921.6927.6927.6955.3755.37
Reserves -7.44-1.23-1.19-1.57-4.15-7.02-12.32-12.369.2011.18
Minority Interest0000000000
Debt0.981.050.9900003.083.213.15
Long Term Debt0.981.050.9900002.483.213.15
Short Term Debt00000000.6000
Trade Payables00.4400.015.547.126.221.372.388.19
Others Liabilities 0.010.010.041.511.686.040.06-0.75-0.111.17
Total Liabilities 0.060.590.1621.6324.7527.8221.6519.0370.0579.05

Fixed Assets

Gross Block0.010.010.010.010.060.070.140.150.170.56
Accumulated Depreciation00000.010.020.030.050.070.20
Net Fixed Assets 00000.050.050.100.100.100.36
CWIP 0000000000
Investments 0007.535.767.812.450.9519.5219.94
Inventories00003.467.689.899.688.848.14
Trade Receivables00.5100.047.037.526.455.719.1013.39
Cash Equivalents 0.050.070.165.202.583.531.611.9918.585.14
Others Assets 0.01008.865.871.221.150.6013.9132.08
Total Assets 0.060.590.1621.6324.7527.8221.6519.0370.0579.05

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.10-0.050.14-6.401.39-2.13-2.34-3.06-2.273.45
PBT 0.100.010.050.291.211.51-0.440.280.473.45
Adjustment 000-0.37-0.54-0.31-0.040.160.29-3.09
Changes in Working Capital 0-0.060.08-6.250.78-2.98-1.83-3.77-2.993.14
Tax Paid 000.01-0.07-0.05-0.35-0.030.26-0.04-0.04
Cash Flow From Investing Activity 000-10.42-4.01-1.410.420.36-29.03-16.45
Capex 0000-0.05-0.01-0.08-0.02-0.02-0.01
Net Investments 000-8.12-1.82-6.230.270.33-17.71-2.59
Others 000-2.30-2.144.830.220.05-11.31-13.85
Cash Flow From Financing Activity -0.100.07-0.0621.8704.5003.0847.89-0.44
Net Proceeds from Shares 00021.36000048.450
Net Proceeds from Borrowing -0.100.070-0.990003.04-0.18-0.06
Interest Paid 00000000.05-0.37-0.25
Dividend Paid 0000000000
Others 00-0.061.5004.500-0.01-0-0.12
Net Cash Flow 00.020.085.04-2.620.96-1.930.3916.59-13.44

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/AN/AN/A2.45.367.81-1.397.330.123.77
ROCE (%)N/AN/AN/A2.655.937.61-2.46225.44
Asset Turnover Ratio01.470.220.030.710.811.11.250.680.44
PAT to CFO Conversion(x)1-2.52.8-27.831.38-1.69N/A-2.73-45.41.4
Working Capital Days
Receivable Days038703578125938789124
Inventory Days0000779511714011194
Payable Days0193006612092592866

Genpharmasec Ltd Stock News

Genpharmasec Ltd FAQs

The current trading price of Genpharmasec on 05-Dec-2025 16:59 is ₹1.38.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Genpharmasec stood at ₹76.41.
The latest P/E ratio of Genpharmasec as of 04-Dec-2025 is 23.34.
The latest P/B ratio of Genpharmasec as of 04-Dec-2025 is 1.11.
The 52-week high of Genpharmasec is ₹4.32 and the 52-week low is ₹1.36.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Genpharmasec is ₹65.57 ( Cr.) .

About Genpharmasec Ltd

Adi Rasayan Limited was incorporated as Public Limited Company on November 16, 1992 and obtained Commencement of Business Certificate on November 20, 1992 with the object, of manufacturing and trading in organic and inorganic chemicals dyes and pigments. The company was promoted by Sanjay J. Adani, Dinesh H. Desai, Dahyabhai Patel, Vikram R. Shah and Mitesh J. Adani and family members.

Subsequently, during October 1994 Shashikant M. Gandhi joined as co-promoter. In early 1993, it was decided by the, Board to set up the project. In April 1993 land admeasuring 19095.36 square metres was acquired at GIDC Industrial Estate, Panoli, Ankleshwar, Bharuch District, Gujarat, for the project. In July 1994, and in December 1994 the company obtained acknowledgements of Memoranda for its products. The company is presently implementing the project. The company is also carrying out a small amount of trading in chemicals.

Adi Rasayan`s registered office is located at Gujarat, India.

Products & Services

  • Pigments, natural
  • Pigments, synthetic

 

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×